drug trials

April 25 | Online Film Screening: The State of Eugenics

Posted on by
Tuesday, April 25 at 3:30 PST
What is the legacy of government sponsored eugenics programs? Learn more and join the discussion following a special screening of THE STATE OF EUGENICS on Tuesday, April 25 at 3:30pm PT presented by Facing History and Ourselves and Reel South.

Between 1933 and 1974, the state of North Carolina ran one of the most aggressive eugenics programs, sterilizing more than 7,600 men, women and children. This film follows the journey of survivors, legislators and journalists who insist the state confront its role in the tragic, forced sterilization of thousands of Americans thought to have “undesirable” genetics.

Duration: 90 minutes

More details are at http://bit.ly/tsoe2017
Promotional Video: https://vimeo.com/195666167
RSVP: http://bit.ly/tsoe2017

Further Reading:

2017 Los Angeles Times Editorial: California needs to do more than apologize to people it sterilized

2016 PBS: Unwanted Sterilization and Eugenics Programs in the United States

2014 Center for Investigative Reporting: Female prison inmates sterilized illegally, California audit confirms

2014 Press Enterprise: Female inmates, some in Chino, unlawfully sterilized

2014 California State AUDIT: Sterilization of Female Inmates Some Inmates Were Sterilized Unlawfully, and Safeguards Designed to Limit Occurrences of the Procedure Failed

2013 Center for Investigative Reporting: Female inmates sterilized in California prisons without approval

2013 Center for Investigative Reporting Video: Sterilized Behind Bars

 

The Science and Politics of Psychedelic Research

Posted on by

Rap Report > The Politics and Science of Psychedelic Research: A Conversation with MAPS

 

Hosted by Ben Roome (Philosophy)

The development of new pharmacological therapies for Post Traumatic Stress Disorder (PTSD) and other mental disorders requires an intricate lattice of practices. The Multidisciplinary Association for Psychedelic Studies has pursued the application of various compounds for therapeutic use for over 20 years. The group’s recent success in carrying out clinical drug trials for the use of MDMA in the treatment of PTSD is the result of careful scientific and political collaboration. In order for these and other trials to be approved by the FDA a complex set of engagements has been developed through painstaking research, careful argument and deep commitment. Bringing key members of MAPS into the space of the Science and Justice Working Group, we will consider unprecedented collaborations and the delicate consensus needed to bring this science more fully into mainstream medicine.

Wednesday, March 2, 2011 | 4:15-6:15 PM | Engineering 2, Room 599